Autoimmune aspects of cytokine and anticytokine therapies
Data up to Jan 2025
Total Citations Per Year
Abstract
References (87)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 • 4,076 citations
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 • 3,152 citations
A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
1987 • 2,769 citations
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 • 2,358 citations
Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes.
1994 • 1,722 citations
Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa
1989 • 1,658 citations
Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein
1997 • 1,651 citations
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
2000 • 1,463 citations
Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis
2000 • 1,211 citations
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
1993 • 1,031 citations
Demyelination occurring during anti-tumor necrosis factor ? therapy for inflammatory arthritides
2001 • 813 citations
A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease
1991 • 785 citations
Treatment of multiple sclerosis with gamma interferon
1987 • 739 citations
A Molecular Basis for MHC Class II—Associated Autoimmunity
1988 • 707 citations
Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α
2002 • 679 citations
T Helper Cell Subsets in Insulin-Dependent Diabetes
1995 • 600 citations
Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis
1988 • 599 citations
The interferons. Mechanisms of action and clinical applications
1991 • 580 citations
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
1998 • 553 citations
Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials
2000 • 535 citations
Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.
1993 • 507 citations
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon
1996 • 498 citations
Side effects of high-dose interferon therapy for chronic hepatitis C
1996 • 469 citations
Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon-α Therapy
1995 • 446 citations
Infliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot Study
2001 • 427 citations
In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon.
1987 • 396 citations
The Interferons
1991 • 380 citations
Etanercept therapy in children with treatment-resistant uveitis
2001 • 309 citations
Enhancement by Interferon of the Specific Cytotoxicity of Sensitized Lymphocytes
1972 • 308 citations
Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy
1990 • 301 citations
Interferon β decreases T cell activation and interferon γ production in multiple sclerosis
1993 • 264 citations
Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy
2000 • 256 citations
Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury.
1989 • 255 citations
Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis
2002 • 249 citations
Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a
1995 • 237 citations
Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
1986 • 233 citations
Serum levels of interferons in patients with systemic lupus erythematosus.
1987 • 180 citations
Immunomodulatory Properties of Interferon‐γ: An Updatea
1998 • 179 citations
Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia.
1995 • 175 citations
Chronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/NZW F1 mice
1989 • 169 citations
Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders
1992 • 165 citations
Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy.
1993 • 160 citations
Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I.
1996 • 156 citations
Infliximab in patients with primary Sj�gren's syndrome: A pilot study
2001 • 153 citations
In Vivo Neutralization of TNF-α Promotes Humoral Autoimmunity by Preventing the Induction of CTL
2001 • 152 citations
Antinuclear Autoantibodies and Lupus Nephritis in Transgenic Mice Expressing Interferon γ in the Epidermis
1997 • 140 citations
Interleukin-2 in Scleroderma: Correlation of Serum Level with Extent of Skin Involvement and Disease Duration
1989 • 134 citations
Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor
2000 • 134 citations
Treatment of multiple myeloma with recombinant alpha-interferon
1986 • 129 citations
Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia
1991 • 128 citations
Leukocytoclastic vasculitis due to etanercept.
2000 • 123 citations
Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis
2002 • 116 citations
Remission of Behcet's syndrome with tumour necrosis factor alpha blocking therapy
2001 • 115 citations
Interferon‐alpha up‐regulates bcl‐2 expression and protects B‐CLL cells from apoptosis in vitro and in vivo
1994 • 109 citations
Interferon-gamma and host antimicrobial defense: Current and future clinical applications
1994 • 109 citations
Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon
1998 • 105 citations
High levels of bcl‐2 protein in circulating t lymphocytes, but not b lymphocytes, of patients with systemic lupus erythematosus
1994 • 103 citations
Multiple sclerosis and chronic inflammatory diseases A case-control study
2009 • 102 citations
Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment.
1993 • 100 citations
Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections
2002 • 100 citations
Severe exacerbation of hepatitis C–associated vasculitic neuropathy following treatment with interferon alpha: A case report and literature review
2002 • 99 citations
Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis.
1991 • 95 citations
Experimental autoimmune encephalomyelitis
1995 • 95 citations
Autoimmune Phenomena in Patients with Malignant Carcinoid Tumors During Interferon-α Treatment
1991 • 92 citations
Autoimmunity Resulting From Cytokine Treatment Predicts Long-Term Survival in Patients With Metastatic Renal Cell Cancer
1999 • 88 citations
Experimental Autoimmune Encephalomyelitis
2004 • 84 citations
Interferon-gamma induced exacerbation of systemic lupus erythematosus.
1990 • 78 citations
Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis
1990 • 76 citations
A randomized, double‐blind study comparing twenty‐four‐week treatment with recombinant interferon‐γ versus placebo in the treatment of rheumatoid arthritis
1997 • 75 citations
Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma.
1987 • 71 citations
Interferon-α and interferon-γ reduce excessive collagen synthesis and procollagen mRNA levels of scleroderma fibroblasts in culture
1988 • 65 citations
Inhibition of interferon-gamma-induced major histocompatibility complex class II gene transcription by interferon-beta and type beta 1 transforming growth factor in human astrocytoma cells. Definition of cis-element.
1993 • 64 citations
Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy
1992 • 50 citations
Maintenance infliximab for Crohn's disease
2002 • 43 citations
Adult onset Still's disease: response to Enbrel
2002 • 36 citations
Impaired tumour necrosis factor-α (TNF-α) production and abnormal B cell response to TNF-α in patients with systemic lupus erythematosus (SLE)
1991 • 35 citations
Induction of antinuclear antibodies in patients with rheumatoid arthritis receiving treatment with human recombinant interferon gamma.
1988 • 33 citations
Autoantibodies in Multiple Sclerosis Patients Before and During IFN-β1b Treatment: Are They Correlated with the Occurrence of Autoimmune Diseases?
2002 • 32 citations
Etanercept in the treatment of psoriatic arthritis and psoriasis
2000 • 27 citations
Modification of Hepatitis B Virus Infection by Recombinant Leukocyte Alpha A Interferon
1986 • 24 citations
Myositis associated with interleukin-2 therapy in a patient with metastatic renal cell carcinoma
1995 • 23 citations
Incomplete Reiter's syndrome induced by systemic interferon α treatment
1993 • 23 citations
Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.
1982 • 23 citations
Rapid exacerbation of scleroderma in a patient treated with interleukin 2 and lymphokine activated killer cells for renal cell carcinoma.
1994 • 20 citations
Interferon-α-Induced Human Lupus Inclusions and p36 Protein in Cancer and AIDS
1996 • 9 citations
It is hazardous to treat HIV patients with interferon-α
2000 • 8 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database